• OPEN AN ACCOUNT
Indian Indices
Sensex
78,745.84 164.84
( 0.21%)
Global Indices
Nasdaq
54,370.92 264.04
(0.49%)
Dow Jones
7,742.03 -15.49
(-0.20%)
Hang Seng
66,265.57 2,308.04
(3.61%)
Nikkei 225
10,894.52 15.14
(0.14%)
Forex
USD-INR
95.23 -0.06
(-0.07%)
EUR-INR
109.68 -0.11
(-0.10%)
GBP-INR
127.98 -0.19
(-0.15%)
JPY-INR
0.60 0.00
(-0.60%)

EQUITY - MARKET SCREENER

Narmada Agrobase Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
543643
INE117Z01029
7.8205893
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NARMADA
29.43
113.89
EPS(TTM)
Face Value()
Div & Yield %
0.51
5
0
 

InvaGen receives EIR report for its facility in Hauppauge, New York
Aug 04,2026
Cipla announced that its wholly owned subsidiary, InvaGen Pharmaceuticals (InvaGen) has received the Establishment Inspection Report (EIR) from the USFDA, indicating the closure of the inspection of its manufacturing facility located at Hauppauge, Long Island, New York, USA.